Xiang M - Search Results

1

Impact of proton radiotherapy on treatment timing in pediatric and adult patients with CNS tumors.

Jin MC, Shi S, Wu A, Sandhu N, Xiang M, Soltys SG, Hiniker S, Li G, Pollom EL. Jin MC, et al. Among authors: xiang m. Neurooncol Pract. 2020 Jun 18;7(6):626-635. doi: 10.1093/nop/npaa034. eCollection 2020 Dec. Neurooncol Pract. 2020. PMID: 33312677 Free PMC article.

2

Adjuvant treatment and survival in older women with triple negative breast cancer: A Surveillance, Epidemiology, and End Results analysis.

Kozak MM, Xiang M, Pollom EL, Horst KC. Kozak MM, et al. Among authors: xiang m. Breast J. 2019 May;25(3):469-473. doi: 10.1111/tbj.13251. Epub 2019 Mar 29. Breast J. 2019. PMID: 30925635

3

Prognostic Factors and Treatment Patterns in the Management of Giant Cell Glioblastoma.

Jin MC, Wu A, Xiang M, Azad TD, Soltys SG, Li G, Pollom EL. Jin MC, et al. Among authors: xiang m. World Neurosurg. 2019 Aug;128:e217-e224. doi: 10.1016/j.wneu.2019.04.103. Epub 2019 Apr 19. World Neurosurg. 2019. PMID: 31009783

4

Physiological motion of the optic chiasm and its impact on stereotactic radiosurgery dose.

Xiang M, Chan C, Wang L, Jani K, Holdsworth SJ, Iv M, Pollom EL, Soltys SG. Xiang M, et al. Br J Radiol. 2019 Jul;92(1099):20190170. doi: 10.1259/bjr.20190170. Epub 2019 May 22. Br J Radiol. 2019. PMID: 31067077 Free PMC article.

5

Survival after neoadjuvant approaches to gastroesophageal junction cancer.

Xiang M, Chang DT, Heestand GM, Pollom EL. Xiang M, et al. Gastric Cancer. 2020 Jan;23(1):175-183. doi: 10.1007/s10120-019-00980-6. Epub 2019 Jun 22. Gastric Cancer. 2020. PMID: 31230228

6

Neoadjuvant treatment strategies for resectable pancreas cancer: A propensity-matched analysis of the National Cancer Database.

Xiang M, Heestand GM, Chang DT, Pollom EL. Xiang M, et al. Radiother Oncol. 2020 Feb;143:101-107. doi: 10.1016/j.radonc.2020.01.007. Epub 2020 Feb 7. Radiother Oncol. 2020. PMID: 32044168

7

Second cancer risk after primary cancer treatment with three-dimensional conformal, intensity-modulated, or proton beam radiation therapy.

Xiang M, Chang DT, Pollom EL. Xiang M, et al. Cancer. 2020 Aug 1;126(15):3560-3568. doi: 10.1002/cncr.32938. Epub 2020 May 19. Cancer. 2020. PMID: 32426866 Free article.

8

Prolongation of definitive head and neck cancer radiotherapy: Survival impact and predisposing factors.

Xiang M, Gensheimer MF, Pollom EL, Holsinger FC, Colevas AD, Le QT, Beadle BM. Xiang M, et al. Radiother Oncol. 2021 Mar;156:201-208. doi: 10.1016/j.radonc.2020.12.025. Epub 2020 Dec 29. Radiother Oncol. 2021. PMID: 33383061

9

Postoperative Observation Versus Radiotherapy for Pathologic N1 Oral Cavity Squamous Cell Carcinoma.

Xiang M, Holsinger FC, Gensheimer MF, Divi V, Pollom EL, Colevas AD, Le QT, Beadle BM. Xiang M, et al. Am J Clin Oncol. 2021 Mar 1;44(3):99-104. doi: 10.1097/COC.0000000000000792. Am J Clin Oncol. 2021. PMID: 33417322

10

Trends and Predictors of Hypofractionated and Intensity-Modulated Radiotherapy for Organ Preservation in Bladder Cancer.

Xiang M, Chang AJ, Chamie K, Drakaki A, Pollom EL, Steinberg ML, Kishan AU. Xiang M, et al. Clin Genitourin Cancer. 2022 Apr;20(2):e94-e103. doi: 10.1016/j.clgc.2021.11.002. Epub 2021 Nov 11. Clin Genitourin Cancer. 2022. PMID: 34866018

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,904 results

Search Page

Filters